Skip to main content
Top
Published in: Magnetic Resonance Materials in Physics, Biology and Medicine 6/2014

01-12-2014 | Research Article

Endometrial cancer: diagnostic value of quantitative measurements of microvascular changes with DCE-MR imaging

Authors: Davide Ippolito, Orazio Minutolo, Anna Cadonici, Cammillo Talei Franzesi, Pietro Bonaffini, Patrizia Perego, Sandro Sironi

Published in: Magnetic Resonance Materials in Physics, Biology and Medicine | Issue 6/2014

Login to get access

Abstract

Object

To assess the diagnostic value of dynamic contrast-enhanced (DCE) perfusion-magnetic resonance imaging (MRI) in detection, characterization and grading of endometrial cancer, using histopathological analysis as the standard of reference.

Materials and methods

Eighty patients with histologically proven endometrial carcinoma who underwent MRI (1.5 T magnet) of the pelvis for staging purposes were enrolled in the study. Each MR examination consisted of multiplanar T2 and T1-weighted turbo spin echo (TSE) sequences and T1-weighted gradient echo sequences before, during and after the administration of contrast medium. For each patient colour perfusion maps were derived from the dynamic sequences using a dedicated workstation. On the maps a region of interest was manually drawn both on normal myometrium and on the endometrial lesion. Then the following perfusion parameters were automatically calculated: relative enhancement (RE, %), maximum enhancement (ME, %), maximum relative enhancement (MRE, %) and time to peak (TTP, s).

Results

All patients underwent total hysterectomy. Histopathological analysis documented: G1 tumour in 21 patients, G2 tumour in 44 patients, G3 tumour in 14 patients and one squamous cell carcinoma. The following mean value perfusion parameters, with corresponding mean standard deviation, were obtained for endometrial cancer: RE (%) = 59.3 ± 36.3; ME (%) = 862.7 ± 475.9; MRE (%) = 75.3 ± 37.6 and TTP (s) = 164.7 ± 78. RE, ME and MRE were lower in tumour lesions than in normal myometrium (p < 0.001) and significantly higher values (p < 0.001) of perfusion parameters were obtained for G1 (well-differentiated) tumours as compared to those in G2 and G3 (moderately and poorly differentiated) lesions.

Conclusion

DCE perfusion-MRI can provide quantitative information on tissue vascularity, which may be of help in detecting endometrial cancer and in the assessment of tumour grading.
Literature
1.
go back to reference Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:825–850CrossRef Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:825–850CrossRef
2.
3.
go back to reference Freeman S, Aly A, Kataoka M, Addley H, Reinhold C, Sala E (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics 32:1805–1827PubMedCrossRef Freeman S, Aly A, Kataoka M, Addley H, Reinhold C, Sala E (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics 32:1805–1827PubMedCrossRef
4.
go back to reference Zuurendonk LD, Smit RA, Mol BW, Feijen HW, de Graaff J, Sykora D, de Winter KA, Wurff A, Snijders MP, Kruitwagen RF (2006) Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur J Surg Oncol 32(4):450–454PubMedCrossRef Zuurendonk LD, Smit RA, Mol BW, Feijen HW, de Graaff J, Sykora D, de Winter KA, Wurff A, Snijders MP, Kruitwagen RF (2006) Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur J Surg Oncol 32(4):450–454PubMedCrossRef
5.
go back to reference Kinkel K, Forstner R, Danza FM, Oleaga L, Cuhna TM, Bergman A, Barentsz JO, Balleyguier C, Brkljacic B, Spencer JA (2009) Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574PubMedCrossRef Kinkel K, Forstner R, Danza FM, Oleaga L, Cuhna TM, Bergman A, Barentsz JO, Balleyguier C, Brkljacic B, Spencer JA (2009) Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574PubMedCrossRef
6.
go back to reference Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L (2005) Endometrial cancer: magnetic resonance imaging. Abdom Imaging 30:626–636PubMedCrossRef Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L (2005) Endometrial cancer: magnetic resonance imaging. Abdom Imaging 30:626–636PubMedCrossRef
7.
go back to reference Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumour imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17(5):509–520PubMedCrossRef Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumour imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17(5):509–520PubMedCrossRef
8.
go back to reference Koyama T, Tamai K, Togashi K (2007) Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 17(8):2009–2019PubMedCrossRef Koyama T, Tamai K, Togashi K (2007) Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 17(8):2009–2019PubMedCrossRef
9.
go back to reference Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16(4):407–422PubMedCrossRef Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16(4):407–422PubMedCrossRef
10.
go back to reference Kitajima K, Suenaga Y, Ueno Y, Kanda T, Maeda T, Makihara N, Ebina Y, Yamada H, Takahashi S, Sugimura K (2014) Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumour: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI. Ann Nucl Med 28(1):25-32 Kitajima K, Suenaga Y, Ueno Y, Kanda T, Maeda T, Makihara N, Ebina Y, Yamada H, Takahashi S, Sugimura K (2014) Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumour: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI. Ann Nucl Med 28(1):25-32
11.
go back to reference He H, Bhosale P, Wei W, Ramalingam P, Iyer R (2013) MRI is highly specific in determining primary cervical versus endometrial cancer when biopsy results are inconclusive. Clin Radiol 68(11):1107–1113PubMedCrossRef He H, Bhosale P, Wei W, Ramalingam P, Iyer R (2013) MRI is highly specific in determining primary cervical versus endometrial cancer when biopsy results are inconclusive. Clin Radiol 68(11):1107–1113PubMedCrossRef
13.
go back to reference Haldorsen I, Gruner R, Husby J, Magnussen IJ, Werner HM, Salvesen OO, Bjørge L, Stefansson I, Akslen LA, Trovik J, Taxt T, Salvesen HB (2013) Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. Eur Radiol 23(10):2916–2925PubMedCrossRef Haldorsen I, Gruner R, Husby J, Magnussen IJ, Werner HM, Salvesen OO, Bjørge L, Stefansson I, Akslen LA, Trovik J, Taxt T, Salvesen HB (2013) Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. Eur Radiol 23(10):2916–2925PubMedCrossRef
14.
go back to reference Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, Jacobs I, Reznek RH (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17:188–196PubMedCrossRef Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, Jacobs I, Reznek RH (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17:188–196PubMedCrossRef
15.
go back to reference Kitajima K, Suenaga Y, Ueno Y, Kanda T, Maeda T, Takahashi S, Ebina Y, Miyahara Y, Yamada H, Sugimura K (2013) Value of fusion PET and MRI for staging of endometrial cancer: comparison with 18F-FDG contrast-enhanced PET/CT and dynamic contrast enhanced pelvic MRI. Eur J Radiol 82:1672–1676PubMedCrossRef Kitajima K, Suenaga Y, Ueno Y, Kanda T, Maeda T, Takahashi S, Ebina Y, Miyahara Y, Yamada H, Sugimura K (2013) Value of fusion PET and MRI for staging of endometrial cancer: comparison with 18F-FDG contrast-enhanced PET/CT and dynamic contrast enhanced pelvic MRI. Eur J Radiol 82:1672–1676PubMedCrossRef
16.
go back to reference Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky JI, Magnotta VA, Berbaum KS, Zhen W, Paulino AC, Oberley LW, Sood AK, Buatti JM (2000) Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 12(6):1027–1033PubMedCrossRef Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky JI, Magnotta VA, Berbaum KS, Zhen W, Paulino AC, Oberley LW, Sood AK, Buatti JM (2000) Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 12(6):1027–1033PubMedCrossRef
17.
go back to reference Postema S, Pattynama PM, van Rijswijk CS, Trimbos JB (1999) Cervical carcinoma: can dynamic contrast-enhanced MR imaging help predict tumour aggressiveness? Radiology 210:217–220PubMedCrossRef Postema S, Pattynama PM, van Rijswijk CS, Trimbos JB (1999) Cervical carcinoma: can dynamic contrast-enhanced MR imaging help predict tumour aggressiveness? Radiology 210:217–220PubMedCrossRef
18.
go back to reference Punwani S (2011) Contrast-enhanced MR imaging of female pelvic cancers: established methods and emerging applications. Eur J Radiol 78:2–11PubMedCrossRef Punwani S (2011) Contrast-enhanced MR imaging of female pelvic cancers: established methods and emerging applications. Eur J Radiol 78:2–11PubMedCrossRef
19.
go back to reference Lim JS, Kim D, Baek SE, Myoung S, Choi J, Shin SJ, Kim MJ, Kim NK, Suh J, Kim KW, Keum KC (2012) Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 22(8):1693–1700PubMedCrossRef Lim JS, Kim D, Baek SE, Myoung S, Choi J, Shin SJ, Kim MJ, Kim NK, Suh J, Kim KW, Keum KC (2012) Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 22(8):1693–1700PubMedCrossRef
20.
go back to reference Turkbey B, Thomason D, Pang Y, Bernardo M, Choyke PL (2010) The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 16:186–192PubMedCentralPubMed Turkbey B, Thomason D, Pang Y, Bernardo M, Choyke PL (2010) The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 16:186–192PubMedCentralPubMed
21.
go back to reference Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumour imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17:509–520PubMedCrossRef Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumour imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17:509–520PubMedCrossRef
22.
go back to reference Inada Y, Matsuki M, Nakai G, Tatsugami F, Tanikake M, Narabayashi I, Yamada T, Tsuji M (2009) Body diffusion-weighted MRI of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 70:122–127PubMedCrossRef Inada Y, Matsuki M, Nakai G, Tatsugami F, Tanikake M, Narabayashi I, Yamada T, Tsuji M (2009) Body diffusion-weighted MRI of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 70:122–127PubMedCrossRef
23.
go back to reference Thomassin-Naggara I, Bazot M, Darai E, Callard P, Thomassin J, Cuenod CA (2008) Epithelial ovarian tumours: value of dynamic contrast-enhanced MR imaging and correlation with tumour angiogenesis. Radiology 248:148–159PubMedCrossRef Thomassin-Naggara I, Bazot M, Darai E, Callard P, Thomassin J, Cuenod CA (2008) Epithelial ovarian tumours: value of dynamic contrast-enhanced MR imaging and correlation with tumour angiogenesis. Radiology 248:148–159PubMedCrossRef
Metadata
Title
Endometrial cancer: diagnostic value of quantitative measurements of microvascular changes with DCE-MR imaging
Authors
Davide Ippolito
Orazio Minutolo
Anna Cadonici
Cammillo Talei Franzesi
Pietro Bonaffini
Patrizia Perego
Sandro Sironi
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Magnetic Resonance Materials in Physics, Biology and Medicine / Issue 6/2014
Print ISSN: 0968-5243
Electronic ISSN: 1352-8661
DOI
https://doi.org/10.1007/s10334-014-0435-6

Other articles of this Issue 6/2014

Magnetic Resonance Materials in Physics, Biology and Medicine 6/2014 Go to the issue